Cardiac arrest & resuscitation

Hypothermia versus normothermia in patients with cardiac arrest and shockable rhythm: a secondary analysis of the TTM-2 study

Crit CarePublished Secondary analysis of the TTM-2 randomised trial

Primary result · SurvivalResult — go to the resultRR for survival 0.96 95% CI 0.81–1.15

Authors' conclusion

In this study, hypothermia at 33˚C did not improve survival or functional outcome in a subset of patients with similar cardiac arrest characteristics to patients in whom benefit from hypothermia was shown in prior studies.

Study context

Population
Out-of-hospital cardiac arrest (OHCA) patients in TTM-2 with characteristics similar to patients in one previous randomised trial showing benefit for hypothermiaof 1891 in TTM-2
Participants
600 patients
Comparison
Hypothermia at 33 °C vs normothermia
  • Hypothermian = 294
  • Normothermian = 306reference
Primary endpoint
Survival
Follow-up
6 months
Methodological detailspost hoc analysis, pragmatic, multicentre
  • Post hoc analysis
  • Pragmatic
  • Multicentre

Primary result

As reported in the abstract

RR for survival

0.96

95% CI 0.81–1.15

P = 0.71

Events by treatment group

Hypothermia vs Normothermia
RR for survival 0.96 (95% CI 0.81–1.15); P = 0.71

Secondary outcomes

OutcomeHypothermiaNormothermiaRR (95% CI)P value
Favorable functional outcome (modified Rankin scale 0-3) · 6 months67.3%66.0%1.03 (0.87–1.23)P = 0.79

Safety

OutcomeHypothermiaNormothermiaOR (95% CI)P value
Arrhythmias21.2%14.1%1.49 (1.05–2.14)P = 0.026

Original publication

Hypothermia versus normothermia in patients with cardiac arrest and shockable rhythm: a secondary analysis of the TTM-2 study. Crit Care. Published 15 October 2024. doi:10.1186/s13054-024-05119-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.